Who owns Bluebird Pharma?
bluebird bio
| Type | Public company |
|---|---|
| Founders | Philippe Leboulch and Irving London |
| Headquarters | Cambridge, Massachusetts, U.S. |
| Key people | Nick Leschly, President & CEO Chip Baird, CFO |
| Products | Zynteglo, Skysona |
Is bluebird bio a good buy?
BLUE has an average analyst recommendation of Buy. The company has an average price target of $29.27. BLUE has an Overall Score of 20.
Is bluebird bio a good company to work for?
bluebird bio is a great place to work Everything and everyone is focus on patient health and well-being. From the guest speakers to the lowly meeting notes you write, you know that what you are doing is going to make a positive difference in someone’s life.
Who founded bluebird bio?
Philippe Leboulch
bluebird bio/Founders
Is Bluebird an American company?
The Blue Bird Corporation (originally known as the Blue Bird Body Company) is an American bus manufacturer headquartered in Fort Valley, Georgia. Blue Bird Body Company was founded in 1932 in Fort Valley, Georgia, as A.L.
Is Bluebird Bio a public company?
bluebird bio’s initial public offering (IPO) occurred on June 19, 2013. bluebird bio is traded on the NASDAQ Global Market under the ticker symbol BLUE, and its CUSIP number is 09609G 100.
Is Zynteglo FDA approved?
The Cambridge, MA biotech announced Monday that the FDA had accepted and given priority review for Zynteglo, its gene therapy for the rare blood disorder beta-thalassemia.
Is BLUE a buy stock?
Out of 9 analysts, 1 (11.11%) are recommending BLUE as a Strong Buy, 1 (11.11%) are recommending BLUE as a Buy, 5 (55.56%) are recommending BLUE as a Hold, 0 (0%) are recommending BLUE as a Sell, and 2 (22.22%) are recommending BLUE as a Strong Sell.
Who is the CEO of bluebird bio?
Nick Leschly (Sep 2010–)
bluebird bio/CEO
Who manufactures Bluebird?
The Blue Bird Corporation (originally known as the Blue Bird Body Company) is an American bus manufacturer headquartered in Fort Valley, Georgia….Blue Bird Corporation.
| Blue Bird Corporation, Fort Valley, Georgia | |
|---|---|
| Key people | Phil Horlock, President and CEO |
| Products | School buses School pupil activity buses |
| Revenue | US$932 million (2016) |
What bank does Bluebird use?
MetaBank®, N.A.
The Bluebird Bank Account is a demand deposit account established by MetaBank®, N.A., Member FDIC.
When did Bluebird go public?
The company’s shares are expected to begin trading on The NASDAQ Global Select Market on Wednesday, June 19, 2013 under the trading symbol “BLUE.”
What is Bluebird Bio Inc known for?
bluebird bio Inc. bluebird bio, Inc. is a clinical-stage biotechnology company. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. It offers the LentiGlobin which is a treatment for transfusion-dependent ß-thalassemia; and Lenti-D as a treatment for cerebral adrenoleukodystrophy.
Is Bluebird Bio’s surge a bellwether for gene editing stocks?
Is bluebird bio’s Surge a Bellwether for Gene Editing Stocks? bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing.
Who are Bluebird Bio competitors?
Competitors of Bluebird Bio include Ionis Pharmaceuticals, Genprex and Bellicum Pharmaceuticals. Where is Bluebird Bio headquarters? Bluebird Bio headquarters is located at 60 Binney St, Cambridge. Where are Bluebird Bio offices?
What does bluebluebird bio do?
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217.